However not all PAF effects are proinflammatory, since PAF is also involved in immunosuppressive mechanisms and consequently, mutations affecting PAF-PAFR signaling may enhance susceptibility to MS in some patients (115). The gene discussed is PCLAF; the disease is myeloid sarcoma.